MedPath
NMPA Approval

通塞脉颗粒

国药准字Z20184086

October 24, 2023

Drug Information

通塞脉颗粒

颗粒剂

每1g相当于饮片3.84g

中药

October 24, 2023

Company Information

Applicant Company

德州市陵城区经济开发区腾达路西首

Manufacturing Company

德州市陵城区经济开发区腾达路西首

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

通塞脉颗粒 - NMPA 批准文号 | MedPath